AMPHOTERICIN B
ANTIFUNGALS-SYSTEMIC·FUNGAL SEPSIS·+22
X-GEN PHARMACEU
Indication
Candidal endocarditis
Candidal endocarditis is a severe, life-threatening fungal infection of the endocardium, most commonly involving native or prosthetic cardiac valves, implantable cardiac devices, or mural endocardium. Read more about Candidal endocarditis
3 drugs 3 manufacturers
Drugs that treat it
Common Candidal endocarditis therapies.
ABELCET (amphotericin B lipid complex)
FUNGAL SEPSIS·+22
SIGMA-TAU
ABELCET (amphotericin B lipid complex)
FUNGAL SEPSIS·+22
SIGMA-TAU/LEADI
Filter & compare in the drug finder →Opens the drug finder with Candidal endocarditis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCandidal endocarditis is a severe, life-threatening fungal infection of the endocardium, most commonly involving native or prosthetic cardiac valves, implantable cardiac devices, or mural endocardium.
Primarily caused by *Candida albicans* or non-albicans *Candida* species such as *Candida parapsilosis*, it typically develops following candidemia in vulnerable populations, including patients with prosthetic heart valves, prolonged central venous catheterization, immunosuppression, or a history of injection drug use.
Pathophysiologically, the yeast adheres to damaged endothelial or prosthetic surfaces and forms robust, biofilm-laden vegetations that are characteristically bulky and prone to fragmentation.
Clinical manifestations range from indolent fever, heart murmurs, and progressive heart failure to acute valvular destruction, perivalvular abscesses, and high rates of major arterial embolic complications.
- nih.gov
Candidal endocarditis is a severe, life-threatening fungal infection of the endocardium, most commonly involving native or prosthetic cardiac valves, implantable cardiac devices, or mural endocardium
- nih.gov
Primarily caused by *Candida albicans* or non-albicans *Candida* species such as *Candida parapsilosis*, it typically develops following candidemia in vulnerable populations, including patients with prosthetic heart valves, prolonged central venous catheterization, immunosuppression, or a history of injection drug use
- nih.gov
Primarily caused by *Candida albicans* or non-albicans *Candida* species such as *Candida parapsilosis*, it typically develops following candidemia in vulnerable populations, including patients with prosthetic heart valves, prolonged central venous catheterization, immunosuppression, or a history of injection drug use
- cdc.gov
Primarily caused by *Candida albicans* or non-albicans *Candida* species such as *Candida parapsilosis*, it typically develops following candidemia in vulnerable populations, including patients with prosthetic heart valves, prolonged central venous catheterization, immunosuppression, or a history of injection drug use
- duke.edu
Primarily caused by *Candida albicans* or non-albicans *Candida* species such as *Candida parapsilosis*, it typically develops following candidemia in vulnerable populations, including patients with prosthetic heart valves, prolonged central venous catheterization, immunosuppression, or a history of injection drug use
- nih.gov
Pathophysiologically, the yeast adheres to damaged endothelial or prosthetic surfaces and forms robust, biofilm-laden vegetations that are characteristically bulky and prone to fragmentation
- nih.gov
Pathophysiologically, the yeast adheres to damaged endothelial or prosthetic surfaces and forms robust, biofilm-laden vegetations that are characteristically bulky and prone to fragmentation Clinical manifestations range from indolent fever, heart murmurs, and progressive heart failure to acute valvular destruction, perivalvular abscesses, and high rates of major arterial embolic complications
- nih.gov
Clinical manifestations range from indolent fever, heart murmurs, and progressive heart failure to acute valvular destruction, perivalvular abscesses, and high rates of major arterial embolic complications
Personalize your experience
Follow Candidal endocarditis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.